AP308

Beyond's analysis on AP308

• 2026-09-08 — Alebund Pharmaceuticals gains FDA clearance to initiate clinical trials for IgA nephropathy treatment

Recent news mentioning AP308

• 2026-09-08 — Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy

Appears alongside

• FDA
• IND
• IgA

Browse the full archive →